Press Release Vanda Pharmaceuticals Granted Orphan Designation for Imsidolimab for the Treatment of Generalized Pustular Psoriasis by the European Commission 13 hours ago
Press Release NEREUS™ Sponsored No. 47 IndyCar Ready for Historic Freedom 250 Grand Prix in Washington, D.C. Aug 22
Press Release Vanda Pharmaceuticals to Announce Second Quarter 2026 Financial Results on August 5, 2026 Jul 29